Hinge Health, Inc.
Hinge Health, Inc. Fundamental Analysis
Hinge Health, Inc. (HNGE) shows moderate financial fundamentals with a PE ratio of -6.27, profit margin of -89.86%, and ROE of -1.32%. The company generates $0.6B in annual revenue with strong year-over-year growth of 33.37%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -149.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze HNGE's fundamental strength across five key dimensions:
Efficiency Score
WeakHNGE struggles to generate sufficient returns from assets.
Valuation Score
ExcellentHNGE trades at attractive valuation levels.
Growth Score
ExcellentHNGE delivers strong and consistent growth momentum.
Financial Health Score
ExcellentHNGE maintains a strong and stable balance sheet.
Profitability Score
WeakHNGE struggles to sustain strong margins.
Key Financial Metrics
Is HNGE Expensive or Cheap?
P/E Ratio
HNGE trades at -6.27 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, HNGE's PEG of -8.62 indicates potential undervaluation.
Price to Book
The market values Hinge Health, Inc. at 8.75 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at -6.60 times EBITDA. This is generally considered low.
How Well Does HNGE Make Money?
Net Profit Margin
For every $100 in sales, Hinge Health, Inc. keeps $-89.86 as profit after all expenses.
Operating Margin
Core operations generate -92.44 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-1.32 in profit for every $100 of shareholder equity.
ROA
Hinge Health, Inc. generates $-70.93 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Hinge Health, Inc. generates strong operating cash flow of $169.71M, reflecting robust business health.
Free Cash Flow
Hinge Health, Inc. generates strong free cash flow of $165.65M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $2.10 in free cash annually.
FCF Yield
HNGE converts 5.12% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-6.27
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-8.62
vs 25 benchmark
P/B Ratio
Price to book value ratio
8.75
vs 25 benchmark
P/S Ratio
Price to sales ratio
5.58
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.02
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.47
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-1.32
vs 25 benchmark
ROA
Return on assets percentage
-0.71
vs 25 benchmark
ROCE
Return on capital employed
-1.42
vs 25 benchmark
How HNGE Stacks Against Its Sector Peers
| Metric | HNGE Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -6.27 | 29.43 | Better (Cheaper) |
| ROE | -132.16% | 800.00% | Weak |
| Net Margin | -89.86% | -20145.00% (disorted) | Weak |
| Debt/Equity | 0.02 | 0.30 | Strong (Low Leverage) |
| Current Ratio | 1.47 | 4.64 | Neutral |
| ROA | -70.93% | -17936.00% (disorted) | Weak |
HNGE outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Hinge Health, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
33.37%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
88.97%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
176.67%
Industry Style: Defensive, Growth, Innovation
High Growth